Jianping Xu

1.7k total citations
81 papers, 1.2k citations indexed

About

Jianping Xu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jianping Xu has authored 81 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 27 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Jianping Xu's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (12 papers) and Cardiac Structural Anomalies and Repair (8 papers). Jianping Xu is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (12 papers) and Cardiac Structural Anomalies and Repair (8 papers). Jianping Xu collaborates with scholars based in China, United States and United Kingdom. Jianping Xu's co-authors include Jia Zheng, Xinhua Xiao, Miao Yu, Lili Mao, Cuijuan Qi, Jing Huang, Xingyuan Wang, Qian Zhang, Qian Zhang and Miao Yu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Jianping Xu

75 papers receiving 1.2k citations

Peers

Jianping Xu
Peter Hsu Australia
Marlene Antônia dos Reis Brazil
Nina Tatevian United States
Daniele Minardi Italy
Roberto Lin Canada
Emmet Hirsch United States
Murat Aral Türkiye
Lilla Tamási Hungary
Darlene A Calhoun United States
James R. Humbert United States
Peter Hsu Australia
Jianping Xu
Citations per year, relative to Jianping Xu Jianping Xu (= 1×) peers Peter Hsu

Countries citing papers authored by Jianping Xu

Since Specialization
Citations

This map shows the geographic impact of Jianping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Xu more than expected).

Fields of papers citing papers by Jianping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Xu. The network helps show where Jianping Xu may publish in the future.

Co-authorship network of co-authors of Jianping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianping Xu. A scholar is included among the top collaborators of Jianping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianping Xu. Jianping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jianping, et al.. (2025). Invasive pulmonary aspergillosis often misdiagnosed as lung cancer: A case report. Medicine. 104(23). e42705–e42705.
2.
3.
4.
Xu, Jianping, et al.. (2022). PEAC: An Ultrasensitive and Cost-Effective MRD Detection System in Non-small Cell Lung Cancer Using Plasma Specimen. Frontiers in Medicine. 9. 822200–822200. 13 indexed citations
5.
Shi, Yuankai, Xin Zhang, Gang Wu, et al.. (2022). Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study. The Lancet Regional Health - Western Pacific. 23. 100452–100452. 10 indexed citations
6.
Zhang, Bo, Ling Qi, Xi Wang, et al.. (2020). Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma. Cancer Communications. 40(12). 711–720. 91 indexed citations
7.
Xu, Jianping, et al.. (2020). Preliminary study on dynamic characteristics of biological characters in growth and development of taro (Colocasia esculenta).. Guangdong nongye kexue. 32(1). 44–48. 1 indexed citations
8.
Jiang, Shiyu, Sheng Yang, Jianliang Yang, et al.. (2019). Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China. BMJ Open. 9(5). e028589–e028589. 1 indexed citations
9.
10.
Zhang, Bo, Xi Wang, Qun Li, et al.. (2019). Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with advanced esophageal squamous cell carcinoma. Chinese Journal of Cancer Research. 31(6). 910–917. 13 indexed citations
11.
Xu, Jianping, et al.. (2018). Diagnostic value of high-frequency ultrasonography in chest wall tuberculosis abscess. 15(3). 209–212. 1 indexed citations
12.
Zheng, Jia, Xinhua Xiao, Qian Zhang, et al.. (2017). The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study. Frontiers in Physiology. 8. 675–675. 50 indexed citations
13.
Mo, Hongnan, Xuezhi Hao, Yutao Liu, et al.. (2016). A prognostic model for platinum‐doublet as second‐line chemotherapy in advanced non‐small‐cell lung cancer patients. Cancer Medicine. 5(6). 1116–1124. 5 indexed citations
14.
Guo, Hongwei, Jianping Xu, Hui Xiong, & Shengshou Hu. (2015). Case studies of two related Chinese patients with Carney complex presenting with extensive cardiac myxomas and PRKAR1A gene mutation of c.491_492delTG. World Journal of Surgical Oncology. 13(1). 83–83. 1 indexed citations
15.
Meng, Jun, et al.. (2015). The features of intestinal tuberculosis by contrast-enhanced ultrasound. Japanese Journal of Radiology. 33(9). 577–584. 6 indexed citations
16.
Zhang, Yongjie, et al.. (2013). Ophiocordyceps sinensis and Cordyceps militaris:research advances, issues and perspectives. Mycosystema. 32(4). 577–597. 15 indexed citations
17.
Xie, Shiyou, et al.. (2009). Application of Arbuscular Mycorrhizas in Ecological Restoration of Rocky Desertification and Analysis of its Foreground. 22(1). 157–160.
18.
Xu, Jianping. (2008). Surgical Treatment of Unroofed Coronary Sinus Syndrome. 1 indexed citations
19.
Xu, Jianping, et al.. (2006). Dehydration of Upper Leaf with Stalk During Flue-curing. Tobacco Science & Technology. 1 indexed citations
20.
Xu, Jianping, et al.. (1998). Study on relativity between oxygen free radical and thromboxane B2, 6-keto-PGF1α during ligustrazine treatment of intrauterine growth retardation. Chinese Journal of Integrative Medicine. 4(3). 223–223. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Hsu Breakdown of academic impact, for papers by Marlene Antônia dos Reis Breakdown of academic impact, for papers by Nina Tatevian Breakdown of academic impact, for papers by Daniele Minardi Breakdown of academic impact, for papers by Roberto Lin Breakdown of academic impact, for papers by Emmet Hirsch Breakdown of academic impact, for papers by Murat Aral Breakdown of academic impact, for papers by Lilla Tamási Breakdown of academic impact, for papers by Darlene A Calhoun Breakdown of academic impact, for papers by James R. Humbert
Rankless by CCL
2026